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Crystal structure of a TAF1-TAF7 complex in human 
transcription factor IID reveals a promoter binding module
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USA
The general transcription factor IID (TFIID) initiates RNA polymerase II-mediated eukaryotic transcription by 
nucleating pre-initiation complex formation at the core promoter of protein-encoding genes. TAF1, the largest in-
tegral subunit of TFIID, contains an evolutionarily conserved yet poorly characterized central core domain, whose 
VSHFL¿FPXWDWLRQGLVUXSWVFHOOSUROLIHUDWLRQLQWKHWHPSHUDWXUHVHQVLWLYHPXWDQWKDPVWHUFHOOOLQHts13. Although the 
impaired TAF1 function in the ts13 mutant has been associated with defective transcriptional regulation of cell cycle 
genes, the mechanism by which TAF1 mediates transcription as part of TFIID remains unclear. Here, we present the 
crystal structure of the human TAF1 central core domain in complex with another conserved TFIID subunit, TAF7, 
which biochemically solubilizes TAF1. The TAF1-TAF7 complex displays an inter-digitated compact architecture, 
featuring an unexpected TAF1 winged helix (WH) domain mounted on top of a heterodimeric triple barrel. The 
single TAF1 residue altered in the ts13 mutant is buried at the junction of these two structural domains. We show 
that the TAF1 WH domain has intrinsic DNA-binding activity, which depends on characteristic residues that are 
commonly used by WH fold proteins for interacting with DNA. Importantly, mutations of these residues not only 
compromise DNA binding by TAF1, but also abrogate its ability to rescue the ts13 mutant phenotype. Together, our 
results resolve the structural organization of the TAF1-TAF7 module in TFIID and unveil a critical promoter-binding 
function of TAF1 in transcription regulation. 
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Introduction
Transcription of protein-encoding genes is vital for the 
survival of all living organisms. Its precise regulation is 
critical for normal cell proliferation, differentiation, and 
development. In eukaryotes, this transcriptional process 
is orchestrated by RNA polymerase II (RNAPII) and 
a set of general transcription factors known as TFIIA, 
TFIIB, TFIID, TFIIE, TFIIF, and TFIIH [1, 2]. These 
factors are sequentially recruited to the core promoters 
of RNAPII-dependent genes and assemble into a tran-
scriptionally competent pre-initiation complex (PIC). By 
directly recognizing the core promoter region of target 
genes, TFIID is responsible for initiating and nucleating 
IXQFWLRQDO3,&DVVHPEO\DWWKH¿UVWVWHSRIWUDQVFULSWLRQ
[3, 4]. 
TFIID is a multi-subunit protein complex, consisting 
of the TATA-binding protein (TBP) and 12-14 TBP-as-
sociated factors (TAFs) [5-7]. TAF1 is the largest subunit 
of TFIID, which interacts with TBP through an N-termi-
nal TBP-binding sequence. TAF1 has also been reported 
to possess various biochemical activities including pro-
tein phosphorylation, histone acetylation, and acetylated 
histone tail recognition activities [8]. In human TAF1, 
these activities have been mapped to the two terminal 
kinase domains, a central domain of unknown function 
(DUF3591 domain), and two tandem bromodomains, 
respectively (Figure 1A) [8-12]. Due to its large size and 
solubility issues, structural information for human TAF1 
is limited to the approximate cryoEM mapping of the 
subunit within TFIID and a high resolution crystal struc-
ture of its tandem bromodomains [5, 12, 13]. The struc-
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Figure 1 Overall structure of the TAF1-TAF7 complex. (A) Domain organization of TAF1 and the TAF1 and TAF7 fragments 
crystallized by the in situ proteolysis method. Different structural domains of the crystallized TAF1 and TAF7 fragments are 
labeled and colored. Regions outlined by dotted lines represent the proteolytically removed segments. (B) Surface represen-
tations of the TAF1-TAF7 complex with structural domains colored with the same scheme as shown in A. TAF1 and TAF7 
are separately shown on the right from the same angle. (C, D) Ribbon diagram of the TAF1-TAF7 complex structure in two 
orthogonal views. The TAF1 and TAF7 protein domains are colored with the same scheme as in A. The TAF1 G716 residue 
mutated in the ts13 hamster cell line is colored in red and indicated by a letter “G”. Dashed lines represent loop regions that 
are not visible in the crystal structure. 
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Figure 2 The TAF1-TAF7 heterodimeric triple barrel. (A) Topology diagram of the TAF1-TAF7 triple barrel in the context of the 
entire crystallized complex of TAF1 and TAF7. Dashed lines represent loop regions not visible in the crystal structure. The 
Gly-rich motif of TAF1 and the Arg-rich motif of TAF7 are highlighted. (B) Ribbon diagram of the TAF1-TAF7 triple barrel core. 
The pseudo two-fold symmetry axis relating the two distal barrels is indicated by the black oval. The residue G716, which is 
mutated in the ts13 hamster cell line, is colored in red and indicated. (C) Ribbon diagram of the RAP74-RAP30 triple barrel.
implicate possible additional functions beyond simple 
scaffolding.
The G716 residue, which is mutated in the ts13 mu-
tant, is strictly conserved among all TAF1 orthologs. This 
UHVLGXHPDSVWRWKH1WHUPLQDOHQGRIWKHVWUDQGȕDQG
lies at the top of the TAF1 barrel. It is completely buried 
IURP WKH VROYHQW E\ WZRĮKHOLFHV LQ WKHĮKHOLFDO GR-
main, which in turn closely pack against the WH domain 
(Figure 2A and 2B). In this position, the G716D muta-
tion will likely perturb the local structure of the TAF1 
EDUUHO DQG DIIHFW WKH WRSRORJLFDO FRQ¿JXUDWLRQEHWZHHQ
the triple barrel and the WH domain at non-permissive 
temperature.
 
Interfaces outside the triple barrel
In addition to the formation of the triple barrel, a 
large portion of the TAF1 fragment and the C-terminal 
VHJPHQW RI WKH7$)SRO\SHSWLGH DGRSW DPL[WXUH RIĮ
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helical and loop structures, which closely wrap around 
the triple barrel core and hold the TAF1 WH domain in 
place (Figure 1B and 1C). The very N-terminal portion 
RIWKH7$)IUDJPHQWIRUPVWZRVKRUWKHOLFHVÀDQNLQJD
long loop, clamping on top of the TAF1 barrel (Supple-
mentary information, Figure S3). The C-terminal region 
of the TAF1 DUF3591 domain, meanwhile, folds into 
¿YHĮKHOLFHVRIYDULDEOHOHQJWKVDQGFRYHUVERWKWKHWRS
and the outer wall of the same barrel. Furthermore, the 
C-terminal segment of the TAF7 fragment adopts a high-
ly coiled structure, plugging one end of the middle barrel 
and closely interacting with the TAF1 C-terminal helical 
region (Figure 1C). Overall, the TAF7 barrel in the com-
plex structure is largely exposed to the solvent, whereas 
the TAF1 barrel is mostly concealed.
Although the crystal structure suggests a central 
role for the triple barrel in stabilizing TAF1-TAF7 in-
teractions, previous studies have shown that the TAF7 
N-terminal sequence involved in triple barrel formation 
is entirely dispensable for TAF1-TAF7 complex assem-
bly [18]. Instead, association with TAF1 hinges on a 
19-amino acid long central region of TAF7 [18], which 
contains a highly conserved Arg-rich motif (Figure 3A). 
In the crystal, this region directly interacts with a highly 
conserved Gly-rich motif in the C-terminal region of the 
TAF1 DUF3591 domain (Figure 3A). The TAF1 Gly-
rich motif is located in the middle of a long loop, which 
coils up and nestles between two TAF1 C-terminal he-
lices. The TAF7 Arg-rich motif forms a one-turn helix 
and packs directly against the TAF1 Gly-rich loop (Fig-
ure 3B). Together, they form a second critical interface 
outside the triple barrel core. Remarkably, this TAF7 
structural element is further embraced by the extreme 
C-terminal end of the TAF1 DUF3591 fragment, which 
harbors at least two phosphorylated Ser/Thr residues 
as suggested by their extra side chain electron densities 
(Supplementary information, Figure S4). 
The RAPiD domain of TAF1, which is absent from the 
structure, has been proposed to interact with the C-termi-
nal domain of TAF7 including the Arg-rich motif (Figure 
3C) [18]. Using recombinant proteins, we assessed the 
ability of the TAF1 RAPiD domain to associate with the 
TAF7 C-terminal portion beyond the Arg-rich motif. Size 
exclusion chromatography analysis showed that the two 
polypeptides were able to form a complex in the absence 
of the TAF1 DUF3591 domain and the TAF7 N-terminal 
region (Figure 3D), indicating that TAF1-TAF7 interac-
tion indeed involves yet another independent interface 
not observed in our current structure. 
The TAF1 winged helix domain 
7KH:+ IROG FRQVLVWV RI WKUHHĮKHOLFHV SDFNLQJ
DJDLQVW WKUHHȕVWUDQGV )LJXUH$ DQG LV IUHTXHQWO\
found in basal transcription factors of RNAPII, subunits 
Figure 3 TAF1-TAF7 interactions between conserved loop motifs and C-terminal regions. (A) Schematic diagram of the 
crystallized TAF1 DUF3591 domain and TAF7 NTD with their conserved Gly-rich and Arg-rich sequence motif, respectively. 
The interacting TAF1 Gly-rich motif and TAF7 Arg-rich motif are colored pale green and bright yellow, and labeled “G” and 
“R”, respectively. Black bar above TAF7 represents the 19-amino acid sequence, which has been documented as a critical 
TAF1-binding region [18]. (B) A close-up view of the interactions between the conserved TAF1 Gly-rich motif and TAF7 Arg-
rich motif, which are colored in the same scheme as shown in A. Dashed lines indicate intermolecular hydrogen bonds and 
salt bridges. The triple barrel in the complex is shown by surface representation. (C) Schematic diagram of the interactions 
between the TAF1 RAPiD domain and the TAF7 CTD. (D)6L]HH[FOXVLRQ FKURPDWRJUDSK\HOXWLRQSUR¿OHVRI WKH LVRODWHG
TAF1-RAPiD domain (brown), the TAF7 CTD (green), and a mixture of the two (purple). Similar to the full-length protein, the 
TAF7 CTD migrates as a larger species on SDS-PAGE.
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Figure 4 The winged helix (WH) domain of TAF1. (A) Superposition of the WH domains of TAF1, the transcription factor 
E2F4, and the yeast HAT ESA1 protein. (B) Electrostatic potential surface of the TAF1 WH domain viewed from the same 
angle as in A and 180° away. The surface colors are clamped between red (௅83.5kTe-1) and blue (+83.5kTe-1). (C) A close-up 
view of the Į8 helix of TAF1 with three solvent-exposed basic residues. (D) Sequence alignment of Į8 helix in the TAF1 WH 
domain. The three basic residues mutated in our studies are highlighted in cyan. 
of RNA Polymerase I and III, and many other transcrip-
tional regulators [27, 28]. These proteins use their WH 
domains to either recognize DNA or mediate protein-pro-
tein interactions. The structure of the TAF1-TAF7 com-
plex unveils a WH domain within the TAF1 DUF3591 
IUDJPHQW HVWDEOLVKLQJ IRU WKH¿UVW WLPH LWV H[LVWHQFH LQ
TFIID. Our previous mutational studies have shown that 
UHPRYDORIWKUHHDPLQRDFLGVLQRQHVSHFL¿F¨
but not other regions of the DUF3591 domain of TAF1 
deprived it of the ability to complement the ts13 defect 
in cell proliferation and cyclin D1 transcription [17]. 
Intriguingly, this deletion mutation maps to the central 
region of the WH domain, indicating a vital role for the 
WH fold in supporting TAF1’s function (Supplementary 
information,  Figure S2). 
Out of a structural homology search using the TAF1 
WH domain as a query, the DNA-binding E2F4 tran-
scription factor stood out as a top hit with an RMSD of 2.1 
cRXW RI  DOLJQHG&Į DWRPV )LJXUH$0RUHRYHU
the 75-residue TAF1 WH domain contains 22 positively 
charged residues, several of which are strictly conserved 
among TAF1 orthologs (Supplementary information, 
Figure S2). With a predicted isoelectric point of 11.3, 
the TAF1 WH domain features several highly basic sur-
face areas (Figure 4B). One of these areas is presented 
E\WKHWKLUGĮKHOL[RIWKH7$):+GRPDLQĮZKLFK
corresponds to a structural element commonly used by 
DNA-binding WH proteins, such as E2F4, to recognize 
the major groove of DNA [28, 29]. Collectively, these 
features of the TAF1 WH domain suggest a possible 
1440
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Figure 5 DNA binding and ts13 cell complementation activities of WT and mutant TAF1 proteins. (A) TAF1 displays 
'1$ELQGLQJDFWLYLW\(06$ZDV FDUULHGRXWZLWK LQFUHDVLQJ FRQFHQWUDWLRQVRI WKH LQGLFDWHGSXUL¿HGSURWHLQV%LQGLQJ UH-
actions were resolved on native 5% polyacrylamide and subjected to autoradiography. The positions of protein-bound and 
-unbound 32P-labeled cyclin D1 (CD1) core promoter fragments are shown. (B) TAF1 binds to double-stranded DNA. TAF1-
TAF7 (22.5 pmoles) was incubated with radiolabeled CD1 probes in the presence of the indicated molar excess amount of 
unlabeled double-stranded or single-stranded CD1. Reaction products were analyzed and detected as described in A. (C) 
0LQLPDO VHTXHQFHVSHFL¿FLW\ IRU7$)'1$ELQGLQJ ,QFUHDVLQJ FRQFHQWUDWLRQVRI7$)7$)FRPSOH[ZDV VXEMHFWHG WR
(06$XVLQJGLIIHUHQWUDGLRODEHOHG'1$SUREHV,0'LQLWLDWRUDQGGRZQVWUHDPUHJLRQRIVXSHUFRUHSURPRWHU&'F\FOLQ'
FRUHSURPRWHU5GV UDQGRPGRXEOHVWUDQGHG'1$VHTXHQFH0LJUDWLRQVRISURWHLQERXQGDQG XQERXQG'1$ IUDJPHQWV
are indicated. (D) Quantitation of DNA binding to the DNA probes described in C. Regions containing the bound and unbound 
UDGLRODEHOHG'1$SUREHVZHUHH[FLVHGIURPWKHGULHGJHODQGTXDQWL¿HGE\OLTXLGVFLQWLOODWLRQ7KHSHUFHQWDJHRIWRWDOFRXQWV
that the shifted complex represented was calculated for each sample. The graphed results are the average from several in-
GHSHQGHQWH[SHULPHQWV,0'n &'n 5GVn = 3. Error bars represent SEM. (E) WH domain mutations abolish 
DNA-binding activity of TAF1. TAF1-TAF7 complexes assembled in insect cells with WT-TAF1 or TAF1-WH mutant (WH3A) 
were analyzed by EMSA. Protein-bound and -unbound 32P-labeled CD1 fragments were detected by autoradiography. (F) 
7$)PXWDWLRQVFRPSURPLVHJURZWKFRPSOHPHQWDWLRQHI¿FLHQF\LQts13 cells. Mutant ts13 cells were transfected with the indi-
cated CS2+ control or TAF1 expression plasmid at 33.5 °C and subsequently shifted to 39.5 °C. After 48-72 h at the elevated 
temperature, the number of viable cells was counted and expressed as a percent relative to cells transfected with WT-TAF1, 
given a value of 100%. The bar graph depicts the average from 4 independent complementation experiments. Error bars, 
6(0&6HPSW\YHFWRU:7:77$)¨GHOHWLRQRIUHVLGXHV:+$5..DOOFKDQJHGWR
DODQLQH'37$$$'37DOOFKDQJHGWRDODQLQH
interaction between the Gly-rich loop in TAF1 and the 
Arg-rich region of TAF7 represents a prominent inter-
face within the complex (Figure 3). To test if disruption 
of this protein interface has any consequences on TFIID 
function, we mutated amino acids D976/P977/T978 in 
the TAF1 Gly-rich loop and examined the ability of the 
resulting DPT-AAA TAF1 mutant to restore cell prolif-
eration to ts13 cells at 39.5 °C. Interestingly, expression 
RI'37$$$ZDVVXI¿FLHQWIRUts13 cells to survive and 
proliferate at the elevated temperature, although the res-
FXHHI¿FLHQF\ZDVWZRIROGORZHUWKDQ:77$))LJXUH
5F). This result suggests that the interface between the 
two conserved TAF1 and TAF7 loops also supports the 
primary function of TAF1 in regulating gene transcrip-
tion. 
Discussion
Despite its important role in TFIID, structure-function 
studies of TAF1 have been held back by its massive yet 
complicated nature and limited validation of its many 
SURSRVHGDFWLYLWLHV2XUVWUXFWXUHRIIHUVWKH¿UVWJOLPSVH
of the human TAF1 central DUF3591 domain, which 
represents the most conserved region of the protein. 
The crystal structure of the TAF1 DUF3591 domain 
in complex with TAF7 reveals an intricately organized 
multi-domain architecture, which is characterized by 
a heterodimeric triple barrel and a multivalent binding 
mode between the two proteins. Such a feature makes it 
possible for TAF7 to act as a dynamic regulator of TAF1 
as suggested by recent studies [34-36]. It might also be 
essential for the large-degree of topological reorganiza-
tion seen with TFIID upon promoter recognition [13]. 
The human TAF1-TAF7 complex shares overall struc-
tural similarity with the recently reported yeast complex 
[20]. Several critical structural elements revealed by both 
studies, such as the triple barrel and WH domain, have 
been previously characterized as key features of general 
transcription factors. These structural features validate 
the physiological authenticity of our structure and sug-
gest that it represents a functional interaction mode of 
TAF1 and TAF7. Because the entire TFIID complex 
likely adopts multiple states during the transcription ini-
tiation process, the conformation of the TAF1-TAF7 sub-
FRPSOH[FDSWXUHGLQRXUVWUXFWXUHPD\UHÀHFWDVSHFL¿F
stage of transcription initiation when TAF1 and TAF7 are 
mutually soluble.
The TAF1 DUF3591 domain has been previously 
reported to possess HAT activity. Surprisingly, the com-
mon structural core shared by many diverse HATs for 
binding the acetyl-CoA cofactor is absent in the TAF1-
TAF7 structure [37]. Although structural homology can 
be found between the WH domains of TAF1 and the 
ESA1 HAT (Figure 4A and Supplementary information, 
Figure S5), the overall fold of the TAF1 DUF3591 do-
main argues against its identity as a HAT. Of note, our 
structure cannot conclusively rule out the HAT function 
of the TAF1 DUF3591 domain, because TAF7 binding 
has been previously documented to inhibit the HAT ac-
tivity of TAF1 [34-36]. It remains possible that TAF7 
binding remodels TAF1 into an enzymatically inactive 
form that might differ significantly from other known 
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essential for the large-degree of topological reorganiza-
tion seen with TFIID upon promoter recognition [13]. 
The human TAF1-TAF7 complex shares overall struc-
tural similarity with the recently reported yeast complex 
[20]. Several critical structural elements revealed by both 
studies, such as the triple barrel and WH domain, have 
been previously characterized as key features of general 
transcription factors. These structural features validate 
the physiological authenticity of our structure and sug-
gest that it represents a functional interaction mode of 
TAF1 and TAF7. Because the entire TFIID complex 
likely adopts multiple states during the transcription ini-
tiation process, the conformation of the TAF1-TAF7 sub-
FRPSOH[FDSWXUHGLQRXUVWUXFWXUHPD\UHÀHFWDVSHFL¿F
stage of transcription initiation when TAF1 and TAF7 are 
mutually soluble.
The TAF1 DUF3591 domain has been previously 
reported to possess HAT activity. Surprisingly, the com-
mon structural core shared by many diverse HATs for 
binding the acetyl-CoA cofactor is absent in the TAF1-
TAF7 structure [37]. Although structural homology can 
be found between the WH domains of TAF1 and the 
ESA1 HAT (Figure 4A and Supplementary information, 
Figure S5), the overall fold of the TAF1 DUF3591 do-
main argues against its identity as a HAT. Of note, our 
structure cannot conclusively rule out the HAT function 
of the TAF1 DUF3591 domain, because TAF7 binding 
has been previously documented to inhibit the HAT ac-
tivity of TAF1 [34-36]. It remains possible that TAF7 
binding remodels TAF1 into an enzymatically inactive 
form that might differ significantly from other known 
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Figure 5 DNA binding and ts13 cell complementation activities of WT and mutant TAF1 proteins. (A) TAF1 displays 
'1$ELQGLQJDFWLYLW\(06$ZDV FDUULHGRXWZLWK LQFUHDVLQJ FRQFHQWUDWLRQVRI WKH LQGLFDWHGSXUL¿HGSURWHLQV%LQGLQJ UH-
actions were resolved on native 5% polyacrylamide and subjected to autoradiography. The positions of protein-bound and 
-unbound 32P-labeled cyclin D1 (CD1) core promoter fragments are shown. (B) TAF1 binds to double-stranded DNA. TAF1-
TAF7 (22.5 pmoles) was incubated with radiolabeled CD1 probes in the presence of the indicated molar excess amount of 
unlabeled double-stranded or single-stranded CD1. Reaction products were analyzed and detected as described in A. (C) 
0LQLPDO VHTXHQFHVSHFL¿FLW\ IRU7$)'1$ELQGLQJ ,QFUHDVLQJ FRQFHQWUDWLRQVRI7$)7$)FRPSOH[ZDV VXEMHFWHG WR
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are indicated. (D) Quantitation of DNA binding to the DNA probes described in C. Regions containing the bound and unbound 
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5GV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DNA-binding activity of TAF1. TAF1-TAF7 complexes assembled in insect cells with WT-TAF1 or TAF1-WH mutant (WH3A) 
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7$)PXWDWLRQVFRPSURPLVHJURZWKFRPSOHPHQWDWLRQHI¿FLHQF\LQts13 cells. Mutant ts13 cells were transfected with the indi-
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been previously characterized as key features of general 
transcription factors. These structural features validate 
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reported to possess HAT activity. Surprisingly, the com-
mon structural core shared by many diverse HATs for 
binding the acetyl-CoA cofactor is absent in the TAF1-
TAF7 structure [37]. Although structural homology can 
be found between the WH domains of TAF1 and the 
ESA1 HAT (Figure 4A and Supplementary information, 
Figure S5), the overall fold of the TAF1 DUF3591 do-
main argues against its identity as a HAT. Of note, our 
structure cannot conclusively rule out the HAT function 
of the TAF1 DUF3591 domain, because TAF7 binding 
has been previously documented to inhibit the HAT ac-
tivity of TAF1 [34-36]. It remains possible that TAF7 
binding remodels TAF1 into an enzymatically inactive 
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HATs. Isolation and structure determination of a soluble 
TAF1 DUF3591 domain free of TAF7 will be needed to 
help resolve this issue. 
Regardless of the mystery of TAF1 as a HAT, our struc-
tural analysis unravels a previously unrecognized WH 
sub-domain within the TAF1 DUF3591 domain, which 
we have shown to possess double-stranded DNA-binding 
activity. Although promoter DNA binding for TAF1 has 
been previously implicated with the cross-species TAF1-
TAF2 subcomplex of TFIID [31], our structure-based 
VWXGLHVUHYHDOIRUWKH¿UVWWLPHWKHVWUXFWXUDOEDVLVRIWKLV
activity. Importantly, we also establish a strong functional 
correlation between promoter DNA binding and the nor-
mal function of TAF1 in transcription and cell cycle regu-
lation. Based on our results, we hypothesize that TAF1, in 
the context of TFIID, likely relies on its promoter DNA 
binding activity to achieve and sustain close contacts with 
the core promoters of genes, including those required for 
cell cycle progression. Once TAF1 is recruited to the pro-
PRWHUUHJLRQWKURXJKHLWKHUVSHFL¿FSURPRWHUUHFRJQLWLRQ
by TBP or the assistance of other TFIID subunits, the WH 
domain of TAF1 provides additional DNA-binding capac-
ity with low sequence preference to allow for the mainte-
nance and subsequent reorganization of the interaction of 
7),,'ZLWK FRUHSURPRWHUVXSRQDUULYDO RI VSHFL¿F UHJ-
ulatory events. The end result is that TAF1 may become 
appropriately armed to mediate the transcription of select 
genes via its proposed enzymatic activity. 
Alternatively, the dynamic interaction of the periph-
eral TFIID subunit TAF7 with TAF1 might differen-
tially modulate the DNA binding activity of TAF1 at 
the promoters of different genes. The modest promoter 
'1$ELQGLQJDI¿QLW\RIWKH7$)7$)PRGXOHPD\EH
necessary to allow the remodeling of TFIID during PIC 
assembly and promote potential interactions between 
the TAF1 WH domain and other transcription regulatory 
factors. Interestingly, in the yeast TAF1-TAF7 structure, 
the TAF1 WH domain is oriented slightly differently 
from the human ortholog, suggesting potential functional 
ÀH[LELOLW\ IRU WKH:+GRPDLQZLWKLQ7),,' LQDGGLWLRQ
to promoter DNA binding activity. 
By combining structural and functional analyses, our 
studies have established the role of TAF1 in promoter 
DNA binding and furnished the missing structural frame-
work for delineating the function of the TAF1-TAF7 
module within TFIID and for understanding the struc-




Human TAF1 (amino acids 600-1236) was co-expressed with 
the human TAF7 full-length protein as a glutathione S-transfer-
ase (GST) fusion protein in High Five (Invitrogen) insect cells. 
The TAF1-TAF7 complex was purified by glutathione affinity 
chromatography using lysis buffer (20 mM Tris-HCl, pH 8.0, 150 
mM NaCl, 1.0 mM DTT) supplemented with protease inhibitors. 
7KHSURWHLQFRPSOH[ZDVIXUWKHUSXUL¿HGE\DQLRQH[FKDQJHDQG
size exclusion chromatography (GE Healthcare) after off-column 
cleavage by the tobacco etch virus (TEV) protease. The eluted 
FRPSOH[ZDVFRQFHQWUDWHGE\XOWUD¿OWUDWLRQWRPJPOLQEXIIHU
containing 25 mM Hepes, pH 7.5, 150 mM NaCl, 1.0 mM DTT. 
Trypsin (0.1% w/w) was added to the complex sample to trim 
RIIÀH[LEOH UHJLRQVGXULQJ FU\VWDOOL]DWLRQ VFUHHQLQJ7KHSURWHLQ
VDPSOHVXVHGIRU(06$DVVD\VZHUHSXUL¿HGWKHVDPHZD\DVGH-
VFULEHGDERYHH[FHSWWKH¿QDOVL]HH[FOXVLRQZDVRPLWWHG
Crystallization and data collection
The crystals of human TAF1-TAF7 complex were obtained at 
4 °C by the hanging-drop vapor diffusion method, using 1.2 µl 
protein complex sample mixed with an equal volume of reservoir 
solution containing 0.2 M potassium sodium tartrate tetrahydrate, 
S+ZY3(*$IWHUEHLQJEULHÀ\HTXLOLEUDWHGLQWKH
reservoir solution, the crystals were transferred to a cryo protectant 
solution containing 25% w/v PEG3350, 0.2 M potassium sodium 
WDUWUDWHWHWUDK\GUDWHS+DQGJO\FHURODQGWKHQÀDVKIUR-
zen in liquid nitrogen. The human TAF1-TAF7 complex heavy 
atom derivative crystals were prepared by soaking the native 
crystals in a buffer containing 0.2 M potassium sodium tartrate tet-
rahydrate, pH 7.4, 20% w/v PEG3350 supplemented with 1.0 mM 
K2Pt(NO2)4 for 12 h, followed by a back soaking in the reservoir 
solution for an additional hour. The crystals were subsequently 
harvested the same way as the native ones. All data sets were 
collected at the BL8.2.1 and BL8.2.2 beamlines at the Advanced 
Light Source of the Lawrence Berkeley National Laboratory. Na-
tive crystals (P212121D cE cF cĮ ȕ 
Ȗ ÛGLIIUDFWHGWRcUHVROXWLRQDQGKHDY\DWRPGHULYDWLYH
crystals (P212121D cE cF cĮ ȕ Ȗ 
ÛGLIIUDFWHGWRcUHVROXWLRQ;UD\GLIIUDFWLRQGDWDVWDWLVWLFV
are shown in Supplementary information, Table S1.
Structure determination
The human TAF1-TAF7 complex structure was determined 
E\6$'SKDVLQJRIDSODWLQXPSURWHLQGHULYDWLYH5HÀHFWLRQGDWD
were indexed, integrated and scaled with the HKL2000 package 
[38]. Experimentally phased map with a well-defined solvent 
boundary and readily interpretable electron density for protein was 
FDOFXODWHGZLWK3+(1,; >@$Q LQLWLDOPRGHOZDV HVWDEOLVKHG
XVLQJ3+(1,;DQG UH¿QHG DJDLQVW WKHQDWLYHGDWD VHW7KH¿QDO
model was manually built with the program COOT [40]. The com-
SOH[VWUXFWXUHZDVUH¿QHGWRDQ5factor = 18.6% and an Rfree = 23.4%. 
Crystallographic data statistics are shown in Supplementary infor-
mation, Table S1. 99.81% of all residues of human TAF1-TAF7 




The TAF1-RAPiD (amino acids 1110-1236) and TAF7-CTD 
(amino acids 154-349) domains were expressed in E. coli in a 
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HATs. Isolation and structure determination of a soluble 
TAF1 DUF3591 domain free of TAF7 will be needed to 
help resolve this issue. 
Regardless of the mystery of TAF1 as a HAT, our struc-
tural analysis unravels a previously unrecognized WH 
sub-domain within the TAF1 DUF3591 domain, which 
we have shown to possess double-stranded DNA-binding 
activity. Although promoter DNA binding for TAF1 has 
been previously implicated with the cross-species TAF1-
TAF2 subcomplex of TFIID [31], our structure-based 
VWXGLHVUHYHDOIRUWKH¿UVWWLPHWKHVWUXFWXUDOEDVLVRIWKLV
activity. Importantly, we also establish a strong functional 
correlation between promoter DNA binding and the nor-
mal function of TAF1 in transcription and cell cycle regu-
lation. Based on our results, we hypothesize that TAF1, in 
the context of TFIID, likely relies on its promoter DNA 
binding activity to achieve and sustain close contacts with 
the core promoters of genes, including those required for 
cell cycle progression. Once TAF1 is recruited to the pro-
PRWHUUHJLRQWKURXJKHLWKHUVSHFL¿FSURPRWHUUHFRJQLWLRQ
by TBP or the assistance of other TFIID subunits, the WH 
domain of TAF1 provides additional DNA-binding capac-
ity with low sequence preference to allow for the mainte-
nance and subsequent reorganization of the interaction of 
7),,'ZLWK FRUHSURPRWHUVXSRQDUULYDO RI VSHFL¿F UHJ-
ulatory events. The end result is that TAF1 may become 
appropriately armed to mediate the transcription of select 
genes via its proposed enzymatic activity. 
Alternatively, the dynamic interaction of the periph-
eral TFIID subunit TAF7 with TAF1 might differen-
tially modulate the DNA binding activity of TAF1 at 
the promoters of different genes. The modest promoter 
'1$ELQGLQJDI¿QLW\RIWKH7$)7$)PRGXOHPD\EH
necessary to allow the remodeling of TFIID during PIC 
assembly and promote potential interactions between 
the TAF1 WH domain and other transcription regulatory 
factors. Interestingly, in the yeast TAF1-TAF7 structure, 
the TAF1 WH domain is oriented slightly differently 
from the human ortholog, suggesting potential functional 
ÀH[LELOLW\ IRU WKH:+GRPDLQZLWKLQ7),,' LQDGGLWLRQ
to promoter DNA binding activity. 
By combining structural and functional analyses, our 
studies have established the role of TAF1 in promoter 
DNA binding and furnished the missing structural frame-
work for delineating the function of the TAF1-TAF7 
module within TFIID and for understanding the struc-
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HATs. Isolation and structure determination of a soluble 
TAF1 DUF3591 domain free of TAF7 will be needed to 
help resolve this issue. 
Regardless of the mystery of TAF1 as a HAT, our struc-
tural analysis unravels a previously unrecognized WH 
sub-domain within the TAF1 DUF3591 domain, which 
we have shown to possess double-stranded DNA-binding 
activity. Although promoter DNA binding for TAF1 has 
been previously implicated with the cross-species TAF1-
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to promoter DNA binding activity. 
By combining structural and functional analyses, our 
studies have established the role of TAF1 in promoter 
DNA binding and furnished the missing structural frame-
work for delineating the function of the TAF1-TAF7 
module within TFIID and for understanding the struc-
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S+ZY3(*$IWHUEHLQJEULHÀ\HTXLOLEUDWHGLQWKH
reservoir solution, the crystals were transferred to a cryo protectant 
solution containing 25% w/v PEG3350, 0.2 M potassium sodium 
WDUWUDWHWHWUDK\GUDWHS+DQGJO\FHURODQGWKHQÀDVKIUR-
zen in liquid nitrogen. The human TAF1-TAF7 complex heavy 
atom derivative crystals were prepared by soaking the native 
crystals in a buffer containing 0.2 M potassium sodium tartrate tet-
rahydrate, pH 7.4, 20% w/v PEG3350 supplemented with 1.0 mM 
K2Pt(NO2)4 for 12 h, followed by a back soaking in the reservoir 
solution for an additional our. he crystals were subsequently 
harvested the same way as the native ones. All data sets were 
collected at the BL8.2.1 and BL8.2.2 beamlines at the Advanced 
Light Source of the Lawrence Berkeley National Laboratory. Na-
tive crystals (P212121D cE cF cĮ ȕ 
Ȗ ÛGLIIUDFWHGWRcUHVROXWLRQDQGKHDY\DWRPGHULYDWLYH
crystals (P212121D cE cF cĮ ȕ Ȗ 
ÛGLIIUDFWHGWRcUHVROXWLRQ;UD\GLIIUDFWLRQGDWDVWDWLVWLFV
are shown in Supplementary information, Table S1.
Structure determination
The human TAF1-TAF7 complex structure was determined 
E\6$'SKDVLQJRIDSODWLQXPSURWHLQGHULYDWLYH5HÀHFWLRQGDWD
were indexed, integrated and scaled with the HKL2000 package 
[38]. Experimentally phased map with a well-defined solvent 
boundary and readily interpretable electron density for protein was 
FDOFXODWHGZLWK3+(1,; >@$Q LQLWLDOPRGHOZDV HVWDEOLVKHG
XVLQJ3+(1,;DQG UH¿QHG DJDLQVW WKHQDWLYHGDWD VHW7KH¿QDO
model was manually built with the program COOT [40]. The com-
SOH[VWUXFWXUHZDVUH¿QHGWRDQ5factor = 18.6% and an Rfree = 23.4%. 
Crystallographic data statistics are shown in Supplementary infor-
mation, Table S1. 99.81% of all residues of human TAF1-TAF7 
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HATs. Isolation and structure determination of a soluble 
TAF1 DUF3591 domain free of TAF7 will be needed to 
help resolve this issue. 
Regardless of the mystery of TAF1 as a HAT, our struc-
tural analysis unravels a previously unrecognized WH 
sub-domain within the TAF1 DUF3591 domain, which 
we have shown to possess double-stranded DNA-binding 
activity. Although promoter DNA binding for TAF1 has 
been previously implicated with the cross-species TAF1-
TAF2 subcomplex of TFIID [31], our structure-based 
VWXGLHVUHYHDOIRUWKH¿UVWWLPHWKHVWUXFWXUDOEDVLVRIWKLV
activity. Importantly, we also establish a strong functional 
correlation between promoter DNA binding and the nor-
mal function of TAF1 in transcription and cell cycle regu-
lation. Based on our results, we hypothesize that TAF1, in 
the context of TFIID, likely relies on its promoter DNA 
binding activity to achieve and sustain close contacts with 
the core promoters of genes, including those required for 
cell cycle progression. Once TAF1 is recruited to the pro-
PRWHUUHJLRQWKURXJKHLWKHUVSHFL¿FSURPRWHUUHFRJQLWLRQ
by TBP or the assistance of other TFIID subunits, the WH 
domain of TAF1 provides additional DNA-binding capac-
ity with low sequence preference to allow for the mainte-
nance and subsequent reorganization of the interaction of 
7),,'ZLWK FRUHSURPRWHUVXSRQDUULYDO RI VSHFL¿F UHJ-
ulatory events. The end result is that TAF1 may become 
appropriately armed to mediate the transcription of select 
genes via its proposed enzymatic activity. 
Alternatively, the dynamic interaction of the periph-
eral TFIID subunit TAF7 with TAF1 might differen-
tially modulate the DNA binding activity of TAF1 at 
the promoters of different genes. The modest promoter 
'1$ELQGLQJDI¿QLW\RIWKH7$)7$)PRGXOHPD\EH
necessary to allow the remodeling of TFIID during PIC 
assembly and promote potential interactions between 
the TAF1 WH domain and other transcription regulatory 
factors. Interestingly, in the yeast TAF1-TAF7 structure, 
the TAF1 WH domain is oriented slightly differently 
from the human ortholog, suggesting potential functional 
ÀH[LELOLW\ IRU WKH:+GRPDLQZLWKLQ7),,' LQDGGLWLRQ
to promoter DNA binding activity. 
By combining structural and functional analyses, our 
studies have established the role of TAF1 in promoter 
DNA binding and furnished the missing structural frame-
work for delineating the function of the TAF1-TAF7 
module within TFIID and for understanding the struc-
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Crystallographic data statistics are shown in Supplementary infor-
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PRGL¿HGS(7D1RYDJHQYHFWRUZLWKDî+LVWDJDQGD3UR-
tein GB1 tag, both cleavable by the TEV protease. Both proteins 
ZHUHSXUL¿HGE\1L17$DI¿QLW\FROXPQVIROORZHGE\RYHUQLJKW
on-column TEV cleavage, and further by anion-exchange and size 
exclusion chromatography (GE Healthcare). To form complex, the 
two polypeptides were mixed in a 1:1 molar ratio, and incubated 
DW&IRURQHKRXU3XUL¿HG7$)5$3L'7$)&7'DQG WKH
IRUPHGFRPSOH[ZHUHDQDO\]HGE\JHO¿OWUDWLRQ7KHHOXWHGFRP-
plex fractions in the shifted peak were analyzed by 15% (w/v) 
SDS-PAGE gel and visualized by Coomassie-blue staining.
EMSA
7$)7$)FRPSOH[SPROHVSXUL¿HGIURPLQVHFWFHOOV
was incubated with 4 ng of 323ƍHQG ODEHOHG'1$SUREHV LQ
mM Hepes pH 7.9, 5 mM MgCl2, 100 mM NaCl, 10% glycerol, 
20 mM tetrasodium pyrophosphate, 0.2 mM dI:dC for 1 hour at 25 
°C. For gel electrophoresis, 6x loading buffer (20% Ficoll, 0.025% 
bromophenol blue) was added and binding reactions were loaded 
onto nondenaturing 5% polyacrylamide (37.5:1 acrylamide:bis) 
WKDWZDVSUHUXQLQî7%(DW9IRUPLQ6DPSOHVZHUH
resolved for 1.5 h at 100 V and shifted complexes detected by au-
WRUDGLRJUDSK\&RPSHWLWLRQ DVVD\VXVLQJSPROHV RI SXUL¿HG
TAF1-TAF7 complex were performed as described above with the 
addition of either unlabeled CD1 core promoter double-stranded 
(20, 40, 80, 200 ng) or sense single-stranded (10, 20, 40, 100 ng) 
'1$WRWKHELQGLQJUHDFWLRQ'1$ELQGLQJZDVTXDQWL¿HGE\H[-
cising the protein bound and unbound DNA bands from the dried 
gels. The amount of radioactivity in each band was measured by 
liquid scintillation (Tri-Carb B2810 TR, PerkinElmer). The per-
cent DNA bound was calculated and plotted using Prism (GraphPad 
Software). The sequences of DNA probes using for EMSA are 
provided in Supplementary information, Table S2.
ts13 cell complementation assays
Mammalian TAF1 expression plasmids contain N-terminal 
HA-tagged TAF1 coding sequence inserted downstream of the 
&09SURPRWHU LQ&6YHFWRU3RLQWPXWDWLRQV LQ7$)ZHUH
introduced by site-directed mutagenesis using the primers shown 
LQ6XSSOHPHQWDU\ LQIRUPDWLRQ7DEOH6 DQG FRQ¿UPHGE\'1$
sequencing. ts13 cells were grown at 33.5 °C in Dulbecco’s modi-
¿HG(DJOHVPHGLXP*LEFRVXSSOHPHQWHGZLWKIHWDOERYLQH
serum, 2 mM L-glutamine, and penicillin/streptomycin. For com-
plementation assays, cells were seeded into 60 mm dishes, grown 
RYHUQLJKWWRFRQÀXHQF\DQGWUDQVIHFWHGZLWKJRI
&6RU7$)H[SUHVVLRQSODVPLGVXVLQJ)X*HQH+' WUDQVIHF-
tion reagent (2:1 FuGene:DNA) according to the manufacturer’s 
protocol (Roche). Transfected cells were maintained an additional 
18-24 h at 33.5 C, after which half the cells were shifted to non-
permissive temperature of 39.5 °C. The number of viable cells was 
determined after 36-48 h at 39.5 °C and the percentage relative to 
WT-TAF1 expression (given the value of 100%) was calculated. 
Accession Code
Coordinates and structure factors have been deposited in the 
Protein Data Bank with accession code 4RGW.
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